TheraPlas facts - Freebase.com

Facts from the Community

From the BioVenturist base

Indication or disease:

Disease	Phase of development
Pancreatic cancer	Pre-clinical development
Brain Cancer	Pre-clinical development
Head and neck cancer	Pre-clinical development
Colorectal cancer	Pre-clinical development
Cardiovascular disease	Pre-clinical development
Breast cancer	Pre-clinical development
Ovarian cancer	Phase I Clinical Trial
Lung cancer	Pre-clinical development

View entire collection »

Developed by:

Expression Genetics Inc.

Stage of development:

In development

top ↑

We can tell you that TheraPlas is a…

…Drug
…Medical Treatment

If you know more about TheraPlas, you can add more facts here »

Similar topics in Freebase

Tezosentan

Tezosentan is a non-selective ETA and ETB receptor antagonist. It acts as a vasodilator and was designed as a therapy for patients with acute heart failure. Recent studies have shown however, that tezosentan does not improve dyspnea or reduce the risk of fatal or nonfatal cardiovascular events.
MK-8998
CEQ600
PF-755,616
MetMAb
PF-2,575,799
GEN - 2nd Generation Anti-CD20
AMY_2nd_Generation_Amylinomimetic
GEN - Anti-IL13
ABI-009

You can help improve this topic by adding more facts here

Edit this topic

Last edited Nov 20, 2008 See all topic history »

Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic

Why do you want to flag this topic?

Freebase data is free for use under the CC-BY license.

Learn more about Freebase licensing and attribution